
In an interview, Vincent Ma, MD, discussed how ctDNA levels after the first cycle of immune checkpoint inhibitor in melanoma could shed light on clinical outcomes.
Vincent Ma, MD, is an assistant professor at the University of Wisconsin School of Medicine and Public Health who specializes in treating melanoma and advanced cutaneous malignancies.

In an interview, Vincent Ma, MD, discussed how ctDNA levels after the first cycle of immune checkpoint inhibitor in melanoma could shed light on clinical outcomes.